CCL2 and neoplasm: The data showed specific deletion of β3 integrin in pericytes does not affect tumor angiogenesis but instead fuels tumor growth by secreting CCL2, thereby directly activating the MEK1-ERK1/2-ROCK2 signaling pathway in tumor cells (Wong et al, 2020).